Tolvaptan and urea in paediatric hyponatraemia.

Faidra VeligratliDemitra AlexandrouSarit ShahRakesh AminMehul DattaniHoong-Wei GanAdeola FamuboniCamilo Lopez-GarciaRichard TrompeterDetlef Bockenhauer

Published in: Pediatric nephrology (Berlin, Germany) (2023)

Tolvaptan and urea appear to be safe and effective when fluid restriction is challenging in paediatric SIADH. A higher resolution version of the Graphical abstract is available as Supplementary information.

Keyphrases

intensive care unit
emergency department
acute heart failure
polycystic kidney disease
single molecule
psychometric properties
heart failure
healthcare